These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 22846154
1. Experimental efficacy of mycophenolate mofetil implant on high-risk corneal allograft rejection and its biocompatibility in the anterior chamber of rabbits. Xin M, Wang T, Shi W, Wu X. J Ocul Pharmacol Ther; 2012 Dec; 28(6):609-17. PubMed ID: 22846154 [Abstract] [Full Text] [Related]
2. [Sustained rapamycin drug delivery system in prevention of high risk corneal allograft rejection and neovascularization in rabbits]. Gao H, Shi WY, Xie LX, Wang SG. Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):6-11. PubMed ID: 16638273 [Abstract] [Full Text] [Related]
4. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant]. Shi W, Xie L, Wang S. Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993 [Abstract] [Full Text] [Related]
5. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits. Shi W, Gao H, Xie L, Wang S. Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400 [Abstract] [Full Text] [Related]
7. Experimental study on the effect of cyclosporine A drug delivery system implanted in anterior chamber on high-risk corneal graft rejection. Xie L, Shi W, Wang Z, Liu Z. Zhonghua Yan Ke Za Zhi; 2002 Jul; 38(7):422-5. PubMed ID: 12411004 [Abstract] [Full Text] [Related]
9. Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study. Szaflik JP, Major J, Izdebska J, Lao M, Szaflik J. Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):307-14. PubMed ID: 26553197 [Abstract] [Full Text] [Related]
10. Survival of corneal allografts following topical treatment with the immunomodulator mycophenolate mofetil. Bertelmann E, de Ruijter M, Gong N, Knapp S, Pleyer U. Ophthalmologica; 2010 Feb; 224(1):38-41. PubMed ID: 19672124 [Abstract] [Full Text] [Related]
11. The biological characteristics and pharmacodynamics of a mycophenolate mofetil nanosuspension ophthalmic delivery system in rabbits. Wu XG, Xin M, Yang LN, Shi WY. J Pharm Sci; 2011 Apr; 100(4):1350-61. PubMed ID: 24081470 [Abstract] [Full Text] [Related]
13. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study. Shi W, Chen M, Xie L, Liu M, Gao H, Wang T, Wu X, Zhao J. Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118 [Abstract] [Full Text] [Related]
14. The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model. Birnbaum F, Schwartzkopff J, Scholz C, Reis A, Reinhard T. Eye (Lond); 2007 Dec; 21(12):1516-23. PubMed ID: 17401326 [Abstract] [Full Text] [Related]
18. Effect of a cyclosporine A delivery system in corneal transplantation. Xie L, Shi W, Wang Z, Bei J, Wang S. Chin Med J (Engl); 2002 Jan; 115(1):110-3. PubMed ID: 11930640 [Abstract] [Full Text] [Related]